Ophthalmology

Latest News

CMS Grants Pass-through Reimbursement for Iheezo
CMS Grants Pass-through Reimbursement for Iheezo

March 13th 2023

Iheezo, approved in September 2022, is an ocular surface anesthesia used during cataract surgeries.

FDA Accepts for Priority Review Drug for Rare Retinal Cancer
FDA Accepts for Priority Review Drug for Rare Retinal Cancer

March 2nd 2023

FDA Sets Goal Date for Blurry Vision Therapy
FDA Sets Goal Date for Blurry Vision Therapy

February 23rd 2023

FDA Approves First Drug for Geographic Atrophy Due to AMD
FDA Approves First Drug for Geographic Atrophy Due to AMD

February 21st 2023

FDA Grants Priority Review to AMD Therapy
FDA Grants Priority Review to AMD Therapy

February 17th 2023

More News

© 2023 MJH Life Sciences

All rights reserved.